How do successive vaccinations and SARS-CoV-2 infections impact humoral immunity dynamics: An 18-month longitudinal study - 03/02/24
Doi : 10.1016/j.jinf.2023.11.006
A.N. Diep 1
Biostatistics and Research Method Center - Public Health Department, Liège University, 4000 Liège, Belgium
J. Schyns 1
Laboratory of Cellular and Molecular Immunology, GIGA Institute, Liège University, 4000 Liège, Belgium
COVID-19 Platform, Liège University, 4000 Liège, Belgium
C. Gourzones 1, E. Goffin
COVID-19 Platform, Liège University, 4000 Liège, Belgium
Laboratory of Immunology-Vaccinology, FARAH, Liège University, 4000 Liège, Belgium
I. Papadopoulos, S. Moges
Biostatistics and Research Method Center - Public Health Department, Liège University, 4000 Liège, Belgium
M. Paridans
From Biostatistics to Health Promotion Research Unit, Public Health Department, Liège University, 4000 Liège, Belgium
N. Gillain, E. Husson
Biostatistics and Research Method Center - Public Health Department, Liège University, 4000 Liège, Belgium
From Biostatistics to Health Promotion Research Unit, Public Health Department, Liège University, 4000 Liège, Belgium
C. Saegerman
Research Unit in Epidemiology and Risk Analysis applied to Veterinary Sciences, FARAH, Liège University, 4000 Liège, Belgium
M. Guillaume 2
From Biostatistics to Health Promotion Research Unit, Public Health Department, Liège University, 4000 Liège, Belgium
Donneau A.F. 2
Biostatistics and Research Method Center - Public Health Department, Liège University, 4000 Liège, Belgium
F. Bureau 2
Laboratory of Cellular and Molecular Immunology, GIGA Institute, Liège University, 4000 Liège, Belgium
COVID-19 Platform, Liège University, 4000 Liège, Belgium
L. Gillet ⁎, 2 
COVID-19 Platform, Liège University, 4000 Liège, Belgium
Laboratory of Immunology-Vaccinology, FARAH, Liège University, 4000 Liège, Belgium
*Correspondence to: Faculty of Veterinary Medicine, University of Liège, Avenue de Cureghem 10, Quartier Vallée 2, 4000 Liège, Belgium.Faculty of Veterinary Medicine, University of LiègeAvenue de Cureghem 10, Quartier Vallée 2Liège4000Belgium
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
Plan
© 2023
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 88 - N° 2
P. 183-186 - février 2024 Retour au numéro
Article précédent
- Identification of a novel HIV-1 circulating recombinant form CRF157_A6C in Primorsky Territory, Russia
- Maksim R. Halikov, Vasily E. Ekushov, Alexei V. Totmenin, Natalya M. Gashnikova, Mariya E. Antonets, Tatyana V. Tregubchak, Lidiia P. Skliar, Natalia P. Solovyova, Irina S. Gorelova, Svetlana N. Beniova
- Efficacy of SIGMAR1-based therapy in the early treatment of confirmed mild symptomatic COVID-19 patients
- Santiago Grau, José Miguel Vela, Alba Gurt, Jaime Barceló-Vidal, Fabiola Ojeda, Iago López, Laura Gómez-García, María Isabel Loza, Elena Martín-García, Rafael Maldonado, Jordi Monfort, SIGMA Group
Bienvenue sur EM-consulte, la référence des professionnels de santé.